IMMURON
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
IMMURON
Industry:
Biopharma Biotechnology
Founded:
1994-01-01
Address:
Armadale, Victoria, Australia
Country:
Australia
Website Url:
http://www.immuron.com
Total Employee:
11+
Status:
Active
Contact:
+610398245254
Email Addresses:
[email protected]
Total Funding:
27.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Cloudflare DNS Amazon Sydney Region Sophos
Similar Organizations
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Current Employees Featured
Stock Details
Company's stock symbol is NASDAQ:IMRN
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Immuron
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-06 | Immuron appoints Mr. Steven Lydeamore as Chief Executive Officer |
Official Site Inspections
http://www.immuron.com
- Host name: 104.21.86.206
- IP address: 104.21.86.206
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 